The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Research Funding - AstraZeneca; GlaxoSmithKline; Iovance Biotherapeutics; Juno Therapeutics; Kite/Gilead
Patents, Royalties, Other Intellectual Property - Lyell Immunopharma
Travel, Accommodations, Expenses - PACT Pharma
KITE-439: A phase I study of HPV16 E7 T cell receptor-engineered T cells in patients with relapsed/refractory HPV16-positive cancers.
 
Kedar Kirtane
Stock and Other Ownership Interests - Immunomedics; Seagen
Research Funding - Kite/Gilead
 
Erminia Massarelli
Honoraria - AstraZeneca; Merck
Consulting or Advisory Role - Genentech/Roche; Nektar
Speakers' Bureau - AstraZeneca; Merck
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Merck (Inst); Pfizer (Inst); Tessa Therapeutics (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Genentech/Roche; Merck; Pfizer
 
Glenn J. Hanna
Honoraria - Bristol-Myers Squibb; Society for Immunotherapy of Cancer
Consulting or Advisory Role - Maverick Therapeutics; Regeneron
Research Funding - Bristol-Myers Squibb (Inst); EMD Serono (Inst); Exicure (Inst); Kartos Therapeutics (Inst); Regeneron (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Maverick Therapeutics; Regeneron
 
Christopher Austin Klebanoff
Stock and Other Ownership Interests - Bluebird Bio; Bristol-Myers Squibb; Celgene; CVS Health; DaVita; Gilead Sciences
Honoraria - Kite, a Gilead company
Consulting or Advisory Role - Achilles Therapeutics; Aleta Biotherapeutics; Bellicum Pharmaceuticals; Bellicum Pharmaceuticals; Bristol-Myers Squibb; Cell Design Labs; G1 Therapeutics; Klus Pharma; Obsidian Therapeutics; Roche/Genentech; RXI Pharmaceuticals
Research Funding - Kite, a Gilead company (Inst); Lilly (Inst); Roche/Genentech (Inst)
 
George Blumenschein
Employment - Janssen; Johnson & Johnson
Stock and Other Ownership Interests - Virogin Biotech
Consulting or Advisory Role - Abbvie; Adicet Bio; Amgen; ARIAD; AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; Clovis Oncology; Genentech; Maverick Therapeutics; MedImmune; Merck; Novartis; Roche; Virogin Biotech; Xcovery
Research Funding - Adaptimmune; AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; Exelis; Genentech; GlaxoSmithKline; Immatics; Immunocore; Incyte; Kite/Gilead; Macrogenics; MedImmune; Merck; Novartis; Roche; Tmunity Therapeutics, Inc.; Torque; Xcovery
 
Michael Russell Bishop
Honoraria - Celgene; Kite/Gilead
Consulting or Advisory Role - Celgene; Juno Therapeutics; Kite/Gilead; Novartis
Speakers' Bureau - Celgene
 
Sylvia Lee
No Relationships to Disclose
 
Jiaxin Niu
No Relationships to Disclose
 
Sabina Adhikary
Employment - Kite, a Gilead company
Stock and Other Ownership Interests - Kite/Gilead
 
Stephanie H. Astrow
Employment - Kite/Gilead
 
Katherine Rodriguez
Employment - Kite/Gilead
 
Rong Chu
Employment - Agensys; Kite/Gilead
Stock and Other Ownership Interests - Allogene Therapeutics; Amgen; Gilead Sciences; Vertex
 
A. Scott Jung
Employment - Kite/Gilead
Stock and Other Ownership Interests - Amgen; Kite/Gilead; Turning Point Therapeutics